Covalon Technologies Ltd V.COV

Alternate Symbol(s): CVALF

Healthcare Biotechnology

Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.

TSXV:COV - Post by User

Covalon Technologies Ltd

Bullboard Posts

Comment by TheRock07on Aug 03, 2016 10:27am

125 Views

Post# 25106028

RE:RE:RE:RE:RE:Company Maker Contract Win: $7.6 million

Yes.

This contract doubles the $7 million in revenues projected from H1 sales of $3.4 million.
So, the current revenue run rate is about $15 million per year.

This excludes any new contracts as well as recent distribution deals including the very large one in the US which might exceed $30 million per year.

So, extremely undervalued below $2..

Bullboard Posts

2024, a breakthrough year for silver